"Targeted therapies" trang 1 - tải miễn phí từ tailieunhanh
Ebook Targeted therapies in cancer: Myth or Reality?

Ebook Targeted therapies in cancer: Myth or Reality?
200    1    1
Ebook Targeted therapies in cancer: Myth or Reality?

Ebook Targeted therapies in cancer: Myth or Reality?
200    1    1
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
7    60    1
Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies
9    70    2
Case report: Whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies

Case report: Whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies
10    53    1
Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
9    35    1
DISORDERS and DISEASES: Cancer

DISORDERS and DISEASES: Cancer
105    49    0
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
9    93    1
Establishment of patient-derived gastric cancer xenografts: A useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways

Establishment of patient-derived gastric cancer xenografts: A useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
11    55    1
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study
10    57    1
Highly sensitive detection of the PIK3CAH1047R mutation in colorectal cancer using a novel PCR-RFLP method

Highly sensitive detection of the PIK3CAH1047R mutation in colorectal cancer using a novel PCR-RFLP method
11    65    1
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
11    45    1
The off-label use of targeted therapies in sarcomas: The OUTC’S program

The off-label use of targeted therapies in sarcomas: The OUTC’S program
11    45    1
Network meta-analysis of targeted therapies for diffuse large B cell lymphoma

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma
10    28    1
How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review
21    35    1
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan

Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan
12    6    1
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
10    66    0
Báo cáo y học:

Báo cáo y học: "γ Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies"
2    28    0
báo cáo khoa học:

báo cáo khoa học: "Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy"
9    95    0
Ebook Personalized treatment options in dermatology (E): Part 1

Ebook Personalized treatment options in dermatology (E): Part 1
79    71    0